Randomized Trial of Continuous Subcutaneous Delivery of Exenatide by ITCA 650 Versus Twice-Daily Exenatide Injections in Metformin-Treated Type 2 Diabetes
Diabetes Care - United States
doi 10.2337/dc12-2410
Full Text
Open PDFAbstract
Available in full text
Date
May 3, 2013
Authors
Publisher
American Diabetes Association